October 17, 2026 05:58 am (IST)
Zydus Cadila receives USFDA approval to market Carboplatin Injection
Ahmedabad, Apr 1 (IBNS) Zydus Cadila, a fully integrated, global healthcare provider, announced on Friday that it has received the final approval from the USFDA to market Carboplatin Injection, 10 mg/ml in 5 ml, 15 ml and 45 ml.
The group now has more than 100 approvals and has so far filed over 280 ANDAs since the commencement of the filing process in FY 2003-04.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Onion prices set to get relief? Centre sends 440 tonnes to Tripura ahead of festive season
Fri, Oct 16 2026
12 nations turn to Bengal: ICC hosts diplomats in Kolkata to explore trade and investment opportunities
Thu, Oct 15 2026
Hyundai announces $15.5 billion India investment plan through 2032: Here's what's coming
Wed, Oct 14 2026
Modi, Anita Anand discuss trade, defence and energy as India-Canada ties gain momentum
Wed, Oct 14 2026
Government approves Fairfax Financial as strategic buyer for 60.72% stake in IDBI Bank
Wed, Oct 14 2026
